Delivery Order SPE2DB22D1103-SPE2DB25FTSH3
Award Date 7/21/25
Potential Completion Date 7/22/25
Potential Value $4.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $2,543.68 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of M-M-R II VACCINE VIALS. The delivery order is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999 with DLA Troop Support Medical for a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. There is no set-aside designation for this...
- This federal contract award, with an ID of SPE2DB24D3013|SPE2DB25FFGMB, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of M-M-R II VACCINE VIALS, valued at $1,424.20, with a firm fixed price and an ultimate completion date of November 15, 2024. The contract is not designated with a set-aside requirement, indicating it was open competition. Amerisourcebergen Drug Corp, a major pharmaceutical distributor and...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,646.68 contract is for the delivery of M-M-R II VACCINE VIALS, with a performance period ending on April 21, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp with the DLA Troop Support Medical, which provides a...
- This is a $1,049.66 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) for the supply of M-M-R II vaccine vials. The award does not have a set-aside designation. Amerisourcebergen is a major pharmaceutical distributor that provides a wide range of prescription drugs, medical supplies, and vaccines to support military treatment facilities and other federal healthcare programs. This delivery order is part of a...
- This is a $1,107.78 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for 4,567,880,630 vials of the M-M-R II (measles, mumps, rubella) vaccine. The delivery order is part of a larger Indefinite Delivery Contract (IDC) the vendor holds with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to supply M-M-R II VACCINE VIALS. The contract has a ceiling value of $9,468.63 and is a firm fixed price contract with a completion date of June 13, 2025. There is no set-aside designation, indicating open competition for this award. Amerisourcebergen Drug Corp is the prime contractor, and this award appears to be part of a larger $999,999,999.00...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is for the delivery of M-M-R II vaccine vials, with a potential value of $2,479.74 and a performance period through January 30, 2024. This delivery order is issued under an indefinite delivery contract (IDC) held by Amerisourcebergen...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide M-M-R II vaccine vials. The contract has a potential value of $1,024.78 and a completion date of February 20, 2024. No set-aside designation was used. Amerisourcebergen Drug Corp is the prime contractor and holds a larger indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The order is for 4,565,386,390 doses of the M-M-R II (Measles, Mumps, and Rubella) vaccine, with a ceiling value of $11,272.36. It is a Firm Fixed Price contract with a period of performance through August 9, 2024. Amerisourcebergen is a major pharmaceutical distributor that has been awarded numerous federal contracts to supply a wide range of medications...
- This federal contract award is for the delivery of M-M-R II vaccine vials to the U.S. government. The $1,489.42 firm fixed-price delivery order was issued by the Defense agency's Medical Supply Chain to the prime contractor, Amerisourcebergen Drug Corp, with no set-aside designation. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the federal government, holds significant Indefinite Delivery Contracts (IDCs) with the Defense Logistics Agency (DLA) Troop...
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB25FTSH3Delivery Order
4568848291 ! M-M-R II VACCINE VIALS
Posted 7/21/25
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 7/21/25 |